Shih‐Jen Liu

3.4k total citations
115 papers, 2.8k citations indexed

About

Shih‐Jen Liu is a scholar working on Immunology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Shih‐Jen Liu has authored 115 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Immunology, 38 papers in Infectious Diseases and 33 papers in Molecular Biology. Recurrent topics in Shih‐Jen Liu's work include Immunotherapy and Immune Responses (57 papers), SARS-CoV-2 and COVID-19 Research (22 papers) and Immune Response and Inflammation (18 papers). Shih‐Jen Liu is often cited by papers focused on Immunotherapy and Immune Responses (57 papers), SARS-CoV-2 and COVID-19 Research (22 papers) and Immune Response and Inflammation (18 papers). Shih‐Jen Liu collaborates with scholars based in Taiwan, United States and China. Shih‐Jen Liu's co-authors include Pele Chong, Hsin–Wei Chen, Chih‐Hsiang Leng, Kuan‐Yin Shen, Mei‐Yu Chen, Ming‐Hsi Huang, Yuan Chen, Yuh‐Pyng Sher, Hsueh‐Hung Liu and Chen-Yi Chiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Shih‐Jen Liu

114 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shih‐Jen Liu Taiwan 28 1.2k 879 766 482 433 115 2.8k
Yasuko Orba Japan 32 863 0.7× 1.3k 1.5× 1.2k 1.6× 543 1.1× 619 1.4× 138 3.9k
Ramesh Akkina United States 39 1.3k 1.0× 1.1k 1.3× 2.3k 3.0× 909 1.9× 277 0.6× 102 4.7k
Yasuhiro Yasutomi Japan 31 1.8k 1.4× 1.1k 1.2× 853 1.1× 1.1k 2.2× 230 0.5× 141 3.9k
Clare Jolly United Kingdom 25 1.4k 1.1× 855 1.0× 843 1.1× 684 1.4× 89 0.2× 44 3.2k
Gerald M. McInerney Sweden 31 737 0.6× 1.4k 1.6× 1.6k 2.1× 457 0.9× 105 0.2× 80 3.7k
Damian F. J. Purcell Australia 36 1.3k 1.1× 1.2k 1.4× 1.5k 2.0× 652 1.4× 140 0.3× 132 4.0k
Joachim Denner Germany 48 625 0.5× 879 1.0× 1.7k 2.2× 550 1.1× 119 0.3× 235 6.7k
Andrew G. D. Bean Australia 35 2.2k 1.8× 1.5k 1.7× 977 1.3× 1.5k 3.1× 419 1.0× 98 4.8k
Frederick Porter United States 7 1.0k 0.8× 1.2k 1.4× 1.9k 2.5× 282 0.6× 344 0.8× 8 3.4k
Jean‐Pierre Y. Scheerlinck Australia 33 1.3k 1.0× 321 0.4× 1.0k 1.3× 667 1.4× 169 0.4× 88 3.5k

Countries citing papers authored by Shih‐Jen Liu

Since Specialization
Citations

This map shows the geographic impact of Shih‐Jen Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shih‐Jen Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shih‐Jen Liu more than expected).

Fields of papers citing papers by Shih‐Jen Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shih‐Jen Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shih‐Jen Liu. The network helps show where Shih‐Jen Liu may publish in the future.

Co-authorship network of co-authors of Shih‐Jen Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shih‐Jen Liu. A scholar is included among the top collaborators of Shih‐Jen Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shih‐Jen Liu. Shih‐Jen Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiang, Chen-Yi, et al.. (2024). SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters. Journal of Virology. 98(2). e0154623–e0154623.
2.
Huang, Yukai, Wei‐Chung Cheng, Juan‐Cheng Yang, et al.. (2024). Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy. Nature Cancer. 5(3). 400–419. 14 indexed citations
3.
Huang, Kai‐Yao, Chi-Ting Huang, Yu‐Ling Lin, et al.. (2023). A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapy. Journal of Experimental & Clinical Cancer Research. 42(1). 29–29. 1 indexed citations
4.
Chen, Wangxue, et al.. (2023). A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge. Emerging Microbes & Infections. 12(2). 2272656–2272656. 1 indexed citations
5.
Sher, Yuh‐Pyng, et al.. (2023). ADAM9 drives immunosuppressive environment for lung tumor progression. The Journal of Immunology. 210(Supplement_1). 172.08–172.08. 1 indexed citations
6.
Lin, Shu‐Min, et al.. (2022). Measurements of Anti-SARS-CoV-2 Antibody Levels after Vaccination Using a SH-SAW Biosensor. Biosensors. 12(8). 599–599. 6 indexed citations
7.
Chiang, Chen-Yi, Szu-Chia Lai, Chia-Yi Yu, et al.. (2022). Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants. JCI Insight. 7(8). 22 indexed citations
8.
Hsu, Chih-Hao, Shiu‐Feng Huang, Yih-Yuan Chen, et al.. (2021). Characterization of Virus Replication, Pathogenesis, and Cytokine Responses in Syrian Hamsters Inoculated with SARS-CoV-2. Journal of Inflammation Research. Volume 14. 3781–3795. 14 indexed citations
9.
Chiang, Chen-Yi, et al.. (2021). A Novel Recombinant Fcγ Receptor-Targeted Survivin Combines with Chemotherapy for Efficient Cancer Treatment. Biomedicines. 9(7). 806–806. 5 indexed citations
10.
Huang, Chiung‐Yi, Chiung‐Yi Huang, I‐Hua Chen, et al.. (2021). Squalene nanoemulsion reinforces mucosal and immunological fingerprints following intravaginal delivery. Biomedicine & Pharmacotherapy. 141. 111799–111799. 11 indexed citations
11.
Chen, Mei‐Yu, et al.. (2020). Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice. Journal of Biomedical Science. 27(1). 51–51. 9 indexed citations
12.
Lai, Jenn‐Haung, Mei‐Yi Wang, Chuan‐Yueh Huang, et al.. (2018). Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells. EMBO Reports. 19(8). 85 indexed citations
13.
Chiang, Chen-Yi, et al.. (2018). Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity. Frontiers in Immunology. 9. 822–822. 9 indexed citations
14.
Shen, Kuan‐Yin, Hsin‐Yu Liu, Huiju Li, et al.. (2016). A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity. Journal of Controlled Release. 233. 57–63. 14 indexed citations
15.
Chiang, Chen-Yi, Chien-Hsiung Pan, Mei‐Yu Chen, et al.. (2016). Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice. Scientific Reports. 6(1). 30648–30648. 33 indexed citations
16.
Song, Ying & Shih‐Jen Liu. (2015). A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms. Scientific Reports. 5(1). 12578–12578. 21 indexed citations
17.
Chen, Weilin, Shih‐Jen Liu, Chih‐Hsiang Leng, et al.. (2013). Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide. Biomaterials. 35(5). 1686–1695. 26 indexed citations
18.
Sher, Yuh‐Pyng, Shih‐Jen Liu, Zhenbo Han, et al.. (2011). Cancer-Targeted BikDD Gene Therapy Elicits Protective Antitumor Immunity against Lung Cancer. Molecular Cancer Therapeutics. 10(4). 637–647. 13 indexed citations
19.
Wang, Sheng‐Fan, Ling Yao, Shih‐Jen Liu, et al.. (2010). Identifying Conserved DR1501-Restricted CD4 + T-Cell Epitopes in Avian H5N1 Hemagglutinin Proteins. Viral Immunology. 23(6). 585–593. 3 indexed citations
20.
Lai, Szu-Chia, Pele Chong, Chia‐Tsui Yeh, et al.. (2005). Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV). Journal of Biomedical Science. 12(5). 711–727. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuko Orba Breakdown of academic impact, for papers by Ramesh Akkina Breakdown of academic impact, for papers by Yasuhiro Yasutomi Breakdown of academic impact, for papers by Clare Jolly Breakdown of academic impact, for papers by Gerald M. McInerney Breakdown of academic impact, for papers by Damian F. J. Purcell Breakdown of academic impact, for papers by Joachim Denner Breakdown of academic impact, for papers by Andrew G. D. Bean Breakdown of academic impact, for papers by Frederick Porter Breakdown of academic impact, for papers by Jean‐Pierre Y. Scheerlinck
Rankless by CCL
2026